Velocity Clinical Research

Velocity Clinical Research

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Velocity Clinical Research is a pioneering, service-based organization in the digital health sector that operates a large, integrated network of clinical trial sites. Founded in 1986, it has grown to over 70 sites and 200 investigators, having conducted more than 15,000 clinical trials. The company's core value proposition is providing sponsors and CROs with operational efficiency, standardized processes, and advanced patient engagement technologies to accelerate clinical development. It positions itself as a strategic partner for trials ranging from single-site studies to complex, high-volume programs.

Digital Health

Technology Platform

Integrated network of clinical trial sites utilizing unified operational processes and next-generation technologies for patient engagement, recruitment, and data collection to ensure standardized, efficient trial execution.

Opportunities

The growing global clinical trials market and persistent industry inefficiencies in patient recruitment create strong demand for Velocity's integrated, high-performance site network.
Expansion in Europe and deepening therapeutic area expertise through specialized councils offer clear paths for growth and premium service offerings.

Risk Factors

Velocity faces risks from dependency on sponsor R&D budgets, intense competition from other site networks and virtual models, and operational execution risk across its large network.
Integrating acquired sites and adapting to evolving regulatory landscapes also present ongoing challenges.

Competitive Landscape

Velocity competes with other large site networks (e.g., ICON's Site Alliance, Parexel's network), independent academic research centers, hospital-based sites, and emerging decentralized/virtual trial providers. Its key differentiator is its fully integrated, standardized operational model across a large, owned site network, promising predictability and scale.